Performance Comparison of Microfluidic and Immunomagnetic Platforms for Pancreatic CTC Enrichment
November 15, 2025
Background
Cyclic Vomiting Syndrome causes severe vomiting episodes with breaks in between periods of wellness. It is first discovered in children by Samuel Gee in 1882.Â
It is a GI disorder causes intense nausea and vomiting episodes lasting hours to days. Diagnosed in children and adults but more common in children.Â
Triggers includes stress, infections, foods, sleep deprivation, and menstrual cycles. Main symptoms are recurrent, stereotypical episodes of severe vomiting, and nausea.Â
Duration of episodes last between a few hours to a few days. Patients noticed symptom-free between episodes.Â
Epidemiology
CVS incidence and prevalence in the US are unknown, with an estimated 2% prevalence in children/adults.Â
Cullen and MacDonald estimated periodic vomiting prevalence in western Australia at 2.3%.Â
White-derived figures may not accurately represent prevalence in all races or ethnic populations. Â
The median age of onset for CVS is 4.8 years, with cases seen in infants to 73-year-olds.Â
Anatomy
Pathophysiology
Study shows CVS patients have higher migraine prevalence in family suggests genetic link.Â
28% of CVS patients vomiting resolves develop migraines, while 80% with familial migraine history responded to treatment.Â
Mutations in mtDNA are linked to CVS pathogenesis. 86% of children with CVS and neuromuscular disease had migraines.Â
In children, high frequency mtDNA polymorphisms may indicate increased susceptibility to the disease.Â
Etiology
Genetic factors are:Â
Familial LinksÂ
Mitochondrial DysfunctionÂ
Neurological factors are:Â
Migraine Association:Â Â
Autonomic Nervous System DysfunctionÂ
Psychological factors are:Â
Stress and AnxietyÂ
Gastrointestinal factors are:Â
Gastric DysrhythmiasÂ
Gut-Brain AxisÂ
Genetics
Prognostic Factors
CVS lasts 2.5 to 5.5 years, that resolves in late childhood or early adolescence but can persist into adulthood. Correlations found between attack duration and hormone levels in study.Â
Frequent and severe episodes raise risk of dehydration, malnutrition, hospitalization, and negative prognosis impact.Â
Patients with infrequent and mild episodes have better outlook and easier management with proper treatment.Â
Clinical History
The clinical history of CVS is crucial for its diagnosis and management. It involves detailed information of the patient’s symptoms, frequency, duration of episodes, and potential triggers.Â
Physical Examination
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
If psychological stressors trigger episodes, stress management techniques or benzodiazepine anxiolytics may help to abort attacks in the early stages. Â
Detailed diary tracks vomiting frequency, pre-meal consumption, and life events to help identify and avoid triggers.Â
Pharmacologic therapy prevents and treats vomiting episodes to reduce frequency and severity.Â
Medication should take daily to prevent frequent or severe migraine episodes effectively.Â
Family history of migraines indicates high response rate to antimigraine medications as first choice.Â
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
use-of-non-pharmacological-approach-for-cyclic-vomiting-syndrome
Balanced diet should be preferred such as fruits, vegetables, whole grains, and lean proteins.Â
Regular physical activity/exercise to improve overall well-being and reduce stress.Â
Regular sleep schedule with consistent bedtimes should be maintained.Â
Ensure a quiet, dark, and comfortable sleeping environment.Â
Proper awareness about CVS should be provided and its related causes with management strategies.Â
Appointments with a pediatrician and preventing recurrence of disorder is an ongoing life-long effort.Â
Use of Antiemetic Agents
It directly acts at the CTZ and vagal afferents from the gastrointestinal tract.Â
Prochlorperazine:Â
It blocks postsynaptic mesolimbic dopamine receptors through its anticholinergic effects.Â
Use of Antihistamines
Cyproheptadine:Â
It is a nonselective antihistamine that acts as appetite stimulant. Â
Their antinausea and antiemetic actions synergistic with 5-HT3 antagonists.Â
Use of Antidepressants
Due to their anticholinergic and sedating side effects it should be taken during bedtime.Â
Use of Beta-Adrenergic Blocking Agents
It reduces the frequency and severity of episodes due to their CNS penetration.Â
Use of anticonvulsants
It blocks glutamate activity to help reduce the frequency and severity of episodes.Â
It initiates GABAergic inhibitory transmission through displacement of negative modulators.Â
Use of Antibiotics
It is a gastric prokinetic that stimulates coordinated gastric emptying. Â
It effectively terminates an episode of CVS to constrict the cerebral vasculature. Â
Use of anxiolytics
It induces sedation and anxiolysis through central inhibition of gamma-aminobutyric acid. Â
use-of-intervention-with-a-procedure-in-treating-cyclic-vomiting-syndrome
Gastrostomy tube placement is performed in patients with severe and frequent episodes that cause significant malnutrition and weight loss.Â
Placement of a nasogastric tube is suggested for temporary relief from vomiting to provide nutrition.Â
use-of-phases-in-managing-cyclic-vomiting-syndrome
In the initial assessment phase, evaluation of medical history, physical examination and laboratory test to confirm diagnosis.Â
Pharmacologic therapy is effective in the treatment phase as it includes use of antiemetic, antihistamine, antibiotic and anxiolytic agents.Â
In supportive care and management phase, patients should receive required attention such as lifestyle modification and intervention therapies.Â
The regular follow-up visits with the pediatrician are scheduled to check the improvement of patients along with treatment response.Â
Medication
5 - 10
mg
Tablet IR:
3-4 times a day
Tablet ER: 10 mg 2 times daily or 15 mg once in the morning
Suppository: 25 mg 2 times daily
IM: 5-10 mg every 3-4 hours; do not exceed 40 mg/day
IV: 2.5-10 mg every 3-4 hours; do not exceed 10 mg/dose or 40 mg/day
0.3-0.65 mg intravenously, intramuscularly, and subcutaneously used for the treatment
Repeat every 6-8 hours if required
ondansetron is meant for prophylaxis of nausea and vomiting caused due to radiation
In the case of total body radiation therapy- 8 mg orally 1-2 hours before the radiation exposure. Later administer the doses every 8 hours for 1-2 days
For single dose fraction- Administer 8 mg orally 1-2 hours before the radiotherapy
Continue the dose every 8 hours after the therapy
Daily abdominal fraction- 8 mg orally 1-2 hours before radiotherapy
Continue the dose every 8 hours after every radiotherapy
Dose Modifications
In case of severe hepatic impairment or a score more than 10 for Child Pugh, do not exceed the dose more than 8 mg per day
Indicated for Dopamine-agonist Anti-Parkinson agents linked to nausea and vomiting
10 mg orally 3 times daily
Do not increase the daily dose to more than 30 mg/day
levomepromazine (methotrimeprazine)Â
25 mg 3-4 times intramuscularly each day
Initially, 6-25 mg orally each day divided into 3 doses with food
Increase the dose based on tolerability and response
levomepromazine (methotrimeprazine)Â
In children and adolescents, 0.25 mg/kg/day orally in 2-3 divided doses
0.0625-0.125 mg/kg/day to be administered as a single dose or in divided doses
Titrate the dose based on its effectiveness
0.0625 mg/kg in D5W as a 250 ml infusion slowly at 20-40 drops/minute
as a prokinetic agent :
500 mcg as malate given Orally thrice a day or 0.5-1 mg as malate given through Intravenous/intramuscular infusion
Take a dose of 10 mg orally for one to three times daily as required
Take a dose of 25 to 50 mg orally as a single dose
Administer 10ml orally twice or thrice a day.
Do not exceed 60mg in a day.
1
mg
Intravenous (IV)
once a day
1mg per dose, i.v, once daily
Max. dose: 3mg daily
(OR)
5mg to 15mg i.m, repeat dose after 4 hours if needed
Maximum dose: 60mg per day
Age: ≥2 years :
Wt (9-13 kg): 2.5 mg orally once or 2 times a day
Do not exceed 7.5 mg a day
Age: ≥2 years
Wt (13.1-18 kg): 2.5 mg 2-3 times daily do not exceed 10 mg per day
Age: ≥2 years
Wt (18.1-37 kg): 2.5 mg orally 3 times daily or 5 mg orally 2 times a day
Do not exceed 15 mg a day
Indicated for Dopamine-agonist Anti-Parkinson agents linked to nausea and vomiting
For children >12 years
10 mg orally 3 times daily
Do not increase the daily dose to more than 30 mg/day
15 to 20 mcg/kg as malate given Orally thrice a day
For >12 years old:
Take a dose of 10 mg orally for one to three times daily as required
<1 year: Safety and efficacy not established
>1 year: Administer 0.5 to 1mg/kg/body weight divided in three doses per day.
200 - 250
mcg/kg
Intramuscular (IM)
For children more than 2.5 years:
200-250mcg/kg i.m once daily
Maximum dose: 10mg
5
mg
Orally 
once a day
0.006 mg/kg intramuscular or subcutaneous as a single dose
Future Trends
Cyclic Vomiting Syndrome causes severe vomiting episodes with breaks in between periods of wellness. It is first discovered in children by Samuel Gee in 1882.Â
It is a GI disorder causes intense nausea and vomiting episodes lasting hours to days. Diagnosed in children and adults but more common in children.Â
Triggers includes stress, infections, foods, sleep deprivation, and menstrual cycles. Main symptoms are recurrent, stereotypical episodes of severe vomiting, and nausea.Â
Duration of episodes last between a few hours to a few days. Patients noticed symptom-free between episodes.Â
CVS incidence and prevalence in the US are unknown, with an estimated 2% prevalence in children/adults.Â
Cullen and MacDonald estimated periodic vomiting prevalence in western Australia at 2.3%.Â
White-derived figures may not accurately represent prevalence in all races or ethnic populations. Â
The median age of onset for CVS is 4.8 years, with cases seen in infants to 73-year-olds.Â
Study shows CVS patients have higher migraine prevalence in family suggests genetic link.Â
28% of CVS patients vomiting resolves develop migraines, while 80% with familial migraine history responded to treatment.Â
Mutations in mtDNA are linked to CVS pathogenesis. 86% of children with CVS and neuromuscular disease had migraines.Â
In children, high frequency mtDNA polymorphisms may indicate increased susceptibility to the disease.Â
Genetic factors are:Â
Familial LinksÂ
Mitochondrial DysfunctionÂ
Neurological factors are:Â
Migraine Association:Â Â
Autonomic Nervous System DysfunctionÂ
Psychological factors are:Â
Stress and AnxietyÂ
Gastrointestinal factors are:Â
Gastric DysrhythmiasÂ
Gut-Brain AxisÂ
CVS lasts 2.5 to 5.5 years, that resolves in late childhood or early adolescence but can persist into adulthood. Correlations found between attack duration and hormone levels in study.Â
Frequent and severe episodes raise risk of dehydration, malnutrition, hospitalization, and negative prognosis impact.Â
Patients with infrequent and mild episodes have better outlook and easier management with proper treatment.Â
The clinical history of CVS is crucial for its diagnosis and management. It involves detailed information of the patient’s symptoms, frequency, duration of episodes, and potential triggers.Â
If psychological stressors trigger episodes, stress management techniques or benzodiazepine anxiolytics may help to abort attacks in the early stages. Â
Detailed diary tracks vomiting frequency, pre-meal consumption, and life events to help identify and avoid triggers.Â
Pharmacologic therapy prevents and treats vomiting episodes to reduce frequency and severity.Â
Medication should take daily to prevent frequent or severe migraine episodes effectively.Â
Family history of migraines indicates high response rate to antimigraine medications as first choice.Â
Pediatrics, General
Balanced diet should be preferred such as fruits, vegetables, whole grains, and lean proteins.Â
Regular physical activity/exercise to improve overall well-being and reduce stress.Â
Regular sleep schedule with consistent bedtimes should be maintained.Â
Ensure a quiet, dark, and comfortable sleeping environment.Â
Proper awareness about CVS should be provided and its related causes with management strategies.Â
Appointments with a pediatrician and preventing recurrence of disorder is an ongoing life-long effort.Â
It directly acts at the CTZ and vagal afferents from the gastrointestinal tract.Â
Prochlorperazine:Â
It blocks postsynaptic mesolimbic dopamine receptors through its anticholinergic effects.Â
Pediatrics, General
Cyproheptadine:Â
It is a nonselective antihistamine that acts as appetite stimulant. Â
Their antinausea and antiemetic actions synergistic with 5-HT3 antagonists.Â
Pediatrics, General
Due to their anticholinergic and sedating side effects it should be taken during bedtime.Â
Pediatrics, General
It reduces the frequency and severity of episodes due to their CNS penetration.Â
Pediatrics, General
It blocks glutamate activity to help reduce the frequency and severity of episodes.Â
It initiates GABAergic inhibitory transmission through displacement of negative modulators.Â
Pediatrics, General
It is a gastric prokinetic that stimulates coordinated gastric emptying. Â
It effectively terminates an episode of CVS to constrict the cerebral vasculature. Â
Pediatrics, General
It induces sedation and anxiolysis through central inhibition of gamma-aminobutyric acid. Â
Pediatrics, General
Gastrostomy tube placement is performed in patients with severe and frequent episodes that cause significant malnutrition and weight loss.Â
Placement of a nasogastric tube is suggested for temporary relief from vomiting to provide nutrition.Â
Pediatrics, General
In the initial assessment phase, evaluation of medical history, physical examination and laboratory test to confirm diagnosis.Â
Pharmacologic therapy is effective in the treatment phase as it includes use of antiemetic, antihistamine, antibiotic and anxiolytic agents.Â
In supportive care and management phase, patients should receive required attention such as lifestyle modification and intervention therapies.Â
The regular follow-up visits with the pediatrician are scheduled to check the improvement of patients along with treatment response.Â
Cyclic Vomiting Syndrome causes severe vomiting episodes with breaks in between periods of wellness. It is first discovered in children by Samuel Gee in 1882.Â
It is a GI disorder causes intense nausea and vomiting episodes lasting hours to days. Diagnosed in children and adults but more common in children.Â
Triggers includes stress, infections, foods, sleep deprivation, and menstrual cycles. Main symptoms are recurrent, stereotypical episodes of severe vomiting, and nausea.Â
Duration of episodes last between a few hours to a few days. Patients noticed symptom-free between episodes.Â
CVS incidence and prevalence in the US are unknown, with an estimated 2% prevalence in children/adults.Â
Cullen and MacDonald estimated periodic vomiting prevalence in western Australia at 2.3%.Â
White-derived figures may not accurately represent prevalence in all races or ethnic populations. Â
The median age of onset for CVS is 4.8 years, with cases seen in infants to 73-year-olds.Â
Study shows CVS patients have higher migraine prevalence in family suggests genetic link.Â
28% of CVS patients vomiting resolves develop migraines, while 80% with familial migraine history responded to treatment.Â
Mutations in mtDNA are linked to CVS pathogenesis. 86% of children with CVS and neuromuscular disease had migraines.Â
In children, high frequency mtDNA polymorphisms may indicate increased susceptibility to the disease.Â
Genetic factors are:Â
Familial LinksÂ
Mitochondrial DysfunctionÂ
Neurological factors are:Â
Migraine Association:Â Â
Autonomic Nervous System DysfunctionÂ
Psychological factors are:Â
Stress and AnxietyÂ
Gastrointestinal factors are:Â
Gastric DysrhythmiasÂ
Gut-Brain AxisÂ
CVS lasts 2.5 to 5.5 years, that resolves in late childhood or early adolescence but can persist into adulthood. Correlations found between attack duration and hormone levels in study.Â
Frequent and severe episodes raise risk of dehydration, malnutrition, hospitalization, and negative prognosis impact.Â
Patients with infrequent and mild episodes have better outlook and easier management with proper treatment.Â
The clinical history of CVS is crucial for its diagnosis and management. It involves detailed information of the patient’s symptoms, frequency, duration of episodes, and potential triggers.Â
If psychological stressors trigger episodes, stress management techniques or benzodiazepine anxiolytics may help to abort attacks in the early stages. Â
Detailed diary tracks vomiting frequency, pre-meal consumption, and life events to help identify and avoid triggers.Â
Pharmacologic therapy prevents and treats vomiting episodes to reduce frequency and severity.Â
Medication should take daily to prevent frequent or severe migraine episodes effectively.Â
Family history of migraines indicates high response rate to antimigraine medications as first choice.Â
Pediatrics, General
Balanced diet should be preferred such as fruits, vegetables, whole grains, and lean proteins.Â
Regular physical activity/exercise to improve overall well-being and reduce stress.Â
Regular sleep schedule with consistent bedtimes should be maintained.Â
Ensure a quiet, dark, and comfortable sleeping environment.Â
Proper awareness about CVS should be provided and its related causes with management strategies.Â
Appointments with a pediatrician and preventing recurrence of disorder is an ongoing life-long effort.Â
It directly acts at the CTZ and vagal afferents from the gastrointestinal tract.Â
Prochlorperazine:Â
It blocks postsynaptic mesolimbic dopamine receptors through its anticholinergic effects.Â
Pediatrics, General
Cyproheptadine:Â
It is a nonselective antihistamine that acts as appetite stimulant. Â
Their antinausea and antiemetic actions synergistic with 5-HT3 antagonists.Â
Pediatrics, General
Due to their anticholinergic and sedating side effects it should be taken during bedtime.Â
Pediatrics, General
It reduces the frequency and severity of episodes due to their CNS penetration.Â
Pediatrics, General
It blocks glutamate activity to help reduce the frequency and severity of episodes.Â
It initiates GABAergic inhibitory transmission through displacement of negative modulators.Â
Pediatrics, General
It is a gastric prokinetic that stimulates coordinated gastric emptying. Â
It effectively terminates an episode of CVS to constrict the cerebral vasculature. Â
Pediatrics, General
It induces sedation and anxiolysis through central inhibition of gamma-aminobutyric acid. Â
Pediatrics, General
Gastrostomy tube placement is performed in patients with severe and frequent episodes that cause significant malnutrition and weight loss.Â
Placement of a nasogastric tube is suggested for temporary relief from vomiting to provide nutrition.Â
Pediatrics, General
In the initial assessment phase, evaluation of medical history, physical examination and laboratory test to confirm diagnosis.Â
Pharmacologic therapy is effective in the treatment phase as it includes use of antiemetic, antihistamine, antibiotic and anxiolytic agents.Â
In supportive care and management phase, patients should receive required attention such as lifestyle modification and intervention therapies.Â
The regular follow-up visits with the pediatrician are scheduled to check the improvement of patients along with treatment response.Â

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
